VEGFA and glioblastoma: The AVAglio study – a phase III trial of BV added to standard radiotherapy and TMZ for patients with newly diagnosed glioblastoma – is an excellent example of a well-designed randomized clinical trial designed to address the utility of VEGF inhibition in this malignancy 37.